Techceuticals has announced its 2026 training schedule for solid dosage manufacturing, featuring a full lineup of two-day, ...
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell ...
Developing New Technology for the Encapsulation of mRNA-Based Vaccines in Lipid Nanoparticles (LNPs)
The COVID-19 pandemic has necessitated the rapid development of new technologies for vaccine development and delivery. One key development has stemmed from the need for largescale production of ...
The new patent-pending technology, branded as JoChe, improves the bioavailability of nutraceuticals and cannabinoids San Diego, California--(Newsfile Corp. - December 19, 2022) - Green Globe ...
CMO's Nottingham site first to use EmulTech's ET4ME technology for GMP production of pharmaceuticals Newcastle and Eindhoven, 18 February, 2013: Aesica, the global contract manufacturing organisation ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
This interview-style Q&A article is with David A. Judd, a cellular biologist and a member of PharmaCyte’s Medical and Scientific Advisory Board. Mr. Judd has over 30 years of experience in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback